Hemocleanse, Inc.

Lafayette, IN 47904

SBIR Award Summary

Total Number of Awards 8
Total Value of Awards $1.01MM
First Award Date 03/15/94
Most Recent Award Date 04/01/05

Key Personnel

Last Name Name Awards Contact
Ash Stephen R Ash 8

8 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PAS-02-149
Budget: 04/01/05 - 09/30/06

DESCRIPTION (provided by applicant): Victims of bacterial bioterrorism agents such as anthrax, plague, and tularemia die very often because of septicemia and subsequent multiple organ dysfunction syndrome (MODS). Viral bioterrorism agents such as smallpox can also induce Systemic Inflammatory Response Syndrome (SIRS) and septic shock because of ...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PAS-02-149
Budget: 04/15/04 - 03/31/05

DESCRIPTION (provided by applicant): Victims of bacterial bioterrorism agents such as anthrax, plague, and tularemia die very often because of septicemia and subsequent multiple organ dysfunction syndrome (MODS). Viral bioterrorism agents such as smallpox can also induce Systemic Inflammatory Response Syndrome (SIRS) and septic shock because of ...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/20/99 - 03/19/00

The Subcutaneous Ultrafilter Infusion Device (SQUID) is a semi- permanent transcutaneous device with 30,000 m.w. cutoff membranes which lie under the skin and distribute drugs to the subcutaneous tissue. The Capillary Filtrate Collector (CFC) is a similar collection of membranes which, under vacuum, creates an ultrafiltrate with the same concent...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic:
Budget: 08/15/98 - 07/14/99

DESCRIPTION: (Adapted from the applicant's abstract) The long-term objective of this proposal is to develop an extracorporeal sorbent based treatment for systemic lupus erythematosus (SLE) and other immunologic disorders. A defining feature of SLE is the presence in the blood of anti-DNA antibodies (Ab...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 01/01/98 - 06/30/98

A novel bioreactor with glass bead matrix (GBM) has been developed at Monsanto and Washington University, in which porcine hepatocytes aggregate into the interstices of the beads, leaving pathways for passage of plasma directly over the cells (as in the native liver). Versus bioreactors with...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 05/15/95 - 10/31/95

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 03/15/95 - 09/14/95

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 03/15/94 - 08/14/94

Acute hepatic failure (AHF) with Stage 4 coma is a serious illness with over 60% mortality when treated with supportive therapy. The BioLogic-DT is an extracorporeal liver support device in which blood passes through cellulosic packages with a suspension of powdered charcoal and cation exchanger sorbents on the opposite side. This device effect...